✦ LIBER ✦

CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo

✍ Scribed by Hiroaki Nishimatsu; Takumi Takeuchi; Tetsuo Ueki; Takahiro Kajiwara; Nobuo Moriyama; Toshimitsu Ishida; Baoxing Li; Tadao Kakizoe; Tadaichi Kitamura

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 453 KB
Volume: 48
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s002620050548

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of vascular endothelial growt

Expression of vascular endothelial growth factor in renal cell carcinomas

✍ V. Paradis; N. Ben Lagha; L. Zeimoura; P. Blanchet; P. Eschwege; N. Ba; G. Benoî 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 349 KB

Expression of laminin γ2 chain monomer e

Expression of laminin γ2 chain monomer enhances invasive growth of human carcinoma cells in vivo

✍ Yoshiaki Tsubota; Takashi Ogawa; Jun Oyanagi; Yoji Nagashima; Kaoru Miyazaki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 918 KB

## Abstract Laminin γ2 chain is a subunit of the heterotrimeric basement membrane protein laminin‐332 (α3β3γ2). The γ2 chain is highly expressed by human cancers at the invasion fronts and this expression correlates with poor prognosis of the cancers. Our previous study showed that the γ2 chain is

Distinct in vivo expression patterns of

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

✍ Csaba Mahotka; Thomas Krieg; Andreas Krieg; Michael Wenzel; Christoph V. Suschek 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB

## Abstract Survivin, a novel member of the inhibitor of apoptosis protein (IAP) family, reduces the susceptibility of tumor cells to proapoptotic stimuli, thereby promoting tumor cell survival during tumor progression and treatment with anticancer drugs. Recently, we identified 2 novel alternative

Expression of transforming growth factor

Expression of transforming growth factor ? in renal cell carcinoma and matched non-involved renal tissue

✍ Mitropoulos, Dionisios ;Kiroudi, Aspasia ;Christelli, Evangelia ;Serafetinidis, 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 345 KB

Vascular endothelial growth factor tight

Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells

✍ Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Masaharu Yamazaki; Masaji Kik 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

## Angiogenesis is essential for the development of a solid tumor, including hepatocellular carcinoma (HCC). HCC is a well-known hypervascular tumor. Vascular endothelial growth factor (VEGF) is one of the most potent angiogenic factors. Its role has not been clarified in vivo in HCC development.

Regulation of CD95 (APO-1/ FAS) ligand a

Regulation of CD95 (APO-1/ FAS) ligand and receptor expression in squamous-cell carcinoma by interferon-γ and cisplatin

✍ Cordula Moers; Ulrich Warskulat; Markus Müschen; Jos Even; Dieter Niederacher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so